Valeo Financial Advisors, LLC Pfizer Inc Transaction History

Valeo Financial Advisors, LLC

$3.81 Billion
Q3 2024

A detailed history of Valeo Financial Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Valeo Financial Advisors, LLC holds 217,790 shares of PFE stock, worth $5.98 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

217,790

Previous 217,209 0.27%

Holding current value

$5.98 Million

Previous $6.08 Million 3.7%

% of portfolio

0.17%

Previous 0.17%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$27.7 - $31.39 $16,093 - $18,237	581 Added 0.27%	217,790 $6.3 Million
Q2 2024 Jul 10, 2024	BUY	$25.26 - $29.6 $636,021 - $745,298	25,179 Added 13.11%	217,209 $6.08 Million
Q1 2024 Apr 25, 2024	BUY	$25.89 - $29.73 $478,343 - $549,291	18,476 Added 10.65%	192,030 $5.33 Million
Q1 2024 Apr 19, 2024	SELL	$25.89 - $29.73 $154,796 - $177,755	-5,979 Reduced 3.33%	173,554 $4.82 Million
Q4 2023 Jan 29, 2024	SELL	$26.13 - $33.94 $364,905 - $473,972	-13,965 Reduced 7.22%	179,533 $5.17 Million
Q3 2023 Oct 19, 2023	SELL	$32.09 - $37.51 $815,791 - $953,579	-25,422 Reduced 11.61%	193,498 $6.42 Million
Q2 2023 Jul 14, 2023	BUY	$36.12 - $41.79 $257,391 - $297,795	7,126 Added 3.36%	218,920 $8.03 Million
Q1 2023 Apr 17, 2023	SELL	$39.39 - $51.28 $55,579 - $72,356	-1,411 Reduced 0.66%	211,794 $8.64 Million
Q4 2022 Feb 09, 2023	BUY	$41.75 - $54.5 $582,162 - $759,948	13,944 Added 7.0%	213,205 $10.9 Million
Q3 2022 Oct 31, 2022	BUY	$43.76 - $53.42 $296,080 - $361,439	6,766 Added 3.51%	199,261 $8.72 Million
Q2 2022 Aug 03, 2022	SELL	$46.53 - $55.17 $757,647 - $898,333	-16,283 Reduced 7.8%	192,495 $10.1 Million
Q1 2022 Apr 28, 2022	BUY	$45.75 - $56.69 $621,285 - $769,850	13,580 Added 6.96%	208,778 $10.8 Million
Q4 2021 Jan 07, 2022	BUY	$41.32 - $61.25 $69,252 - $102,655	1,676 Added 0.87%	195,198 $11.5 Million
Q3 2021 Nov 02, 2021	BUY	$39.25 - $50.42 $796,618 - $1.02 Million	20,296 Added 11.72%	193,522 $8.32 Million
Q2 2021 Jul 22, 2021	BUY	$35.91 - $40.68 $237,472 - $269,016	6,613 Added 3.97%	173,226 $6.78 Million
Q1 2021 Apr 12, 2021	BUY	$33.49 - $37.77 $316,781 - $357,266	9,459 Added 6.02%	166,613 $6.04 Million
Q4 2020 Feb 11, 2021	BUY	$33.47 - $42.56 $383,934 - $488,205	11,471 Added 7.87%	157,154 $5.79 Million
Q3 2020 Oct 28, 2020	SELL	$31.75 - $37.25 $639,286 - $750,028	-20,135 Reduced 12.14%	145,683 $5.35 Million
Q2 2020 Jul 20, 2020	BUY	$30.12 - $36.54 $1.12 Million - $1.36 Million	37,110 Added 28.83%	165,818 $5.42 Million
Q1 2020 Apr 13, 2020	BUY	$27.03 - $38.62 $96,226 - $137,487	3,560 Added 2.84%	128,708 $4.55 Million
Q4 2019 Jan 24, 2020	BUY	$32.92 - $37.36 $137,045 - $155,529	4,163 Added 3.44%	125,148 $4.9 Million
Q3 2019 Oct 15, 2019	BUY	$32.49 - $42.13 $158,746 - $205,847	4,886 Added 4.21%	120,985 $4.35 Million
Q2 2019 Jul 10, 2019	BUY	$36.98 - $41.52 $61,312 - $68,840	1,658 Added 1.45%	116,099 $5.03 Million
Q1 2019 Apr 12, 2019	BUY	$37.5 - $41.2 $4,125 - $4,532	110 Added 0.1%	114,441 $4.86 Million
Q4 2018 Jan 30, 2019	BUY	$38.47 - $43.86 $22,812 - $26,008	593 Added 0.52%	114,331 $4.99 Million
Q3 2018 Nov 01, 2018	SELL	$34.47 - $41.81 $62,183 - $75,425	-1,804 Reduced 1.56%	113,738 $4.9 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $35,288 - $37,621	1,070 Added 0.93%	115,542 $4.72 Million
Q1 2018 Apr 12, 2018	BUY	$31.91 - $37.02 $91,422 - $106,062	2,865 Added 2.57%	114,472 $4.06 Million
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $413,588 - $438,831	12,435 Added 12.54%	111,607 $4.04 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $3.07 Million - $3.39 Million	99,172	99,172 $3.54 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.

Account

Valeo Financial Advisors, LLC Pfizer Inc Transaction History